Methods for treating bone deficit conditions with benzothiazole
US5922753A · kind A · utility
Assignees
Inventors
Key dates
| Filing date | Feb 28, 1997 |
| Grant date | Jul 13, 1999 |
| Priority date | — |
| Expiry date | Feb 28, 2017 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/4184
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds containing two aromatic systems covalently linked through a linker containing one or more atoms, or "linker" defined as including a covalent bond per se so as to space the aromatic systems at a distance 1.5-15 .ANG., are effective in treating conditions associated with bone deficits. The compounds can be administered to vertebrate subjects alone or in combination with additional agents that promote bone growth or that inhibit bone resorption. They can be screened for activity prior to administration by assessing their ability to effect the transcription of a reporter gene coupled to a promoter associated with a bone morphogenetic protein and/or their ability to stimulate calvarial growth in model animal systems.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.